Read articles from Oceania

November 20, 2026 by gfn.tv

GFN.TV Interviews #98 | CRITICAL MASS | Global Safer Nicotine Use Reaches 200 Million

An estimated 200 million people worldwide now use safer nicotine products, according to the latest GSTHR Situation Report, with global vaping numbers nearly doubling over the past five years.

In the latest GFN.TV interview, economist Giorgi Mzhavanadze examines this growing transition, including evidence that smoke-free alternatives are increasingly replacing cigarettes in several countries.

However, rising use alone does not guarantee public health benefits. The key measure of tobacco harm reduction remains the number of people who successfully move away from combustible tobacco, supported by affordable access, consumer choice and proportionate regulation.

November 19, 2026 by nzherald.co.nz

Smoking rate falls below 6% for first time, daily vaping declines slightly

New Zealand's daily smoking rate has fallen below 6% for the first time, reaching 5.9% in the latest national health survey, down from 6.7% the previous year. Daily vaping also declined slightly, from 11.7% to 11.2%.

The figures mark continued progress in reducing cigarette use, although smoking rates remain considerably higher among Māori and Pacific communities.

New Zealand's experience highlights the importance of maintaining effective cessation support and access to lower-risk nicotine alternatives, while addressing persistent inequalities in smoking-related harm.

November 18, 2026 by acsh.org

Vaping and lung cancer: Here's what we know (and what we don't)

The long-term relationship between vaping and lung cancer remains uncertain, but existing evidence provides important distinctions between e-cigarettes and combustible tobacco.

Research shows that switching completely from smoking to vaping substantially reduces exposure to carcinogenic chemicals, including tobacco-specific nitrosamines. However, decades of follow-up are still needed to establish long-term cancer risks.

The findings reinforce the importance of distinguishing reduced toxicant exposure from proven reductions in disease risk, while recognising the potential role of vaping in tobacco harm reduction.

November 16, 2026 by substack.com

The Double Standard Behind the “False Promise”

The debate over nicotine pouches in New Zealand has exposed an important double standard in tobacco control research.

While critics demand stronger evidence that pouches support smoking cessation, the potential consequences of restricting access receive considerably less scrutiny. Existing research remains limited, but uncertainty about the benefits of nicotine pouches does not establish that prohibition produces better public health outcomes.

A balanced approach should apply the same scientific standards to both harm reduction interventions and restrictive policies, measuring success through actual changes in smoking behaviour and health outcomes.

November 12, 2026 by clivebates.com

Evidence sent to the WHO review of nicotine

The WHO's upcoming review of nicotine could have significant implications for the future of tobacco harm reduction.

Following Palau's proposal to bring nicotine under the UN Convention on Psychotropic Substances, a detailed evidence briefing has been submitted to the WHO Expert Committee on Drug Dependence ahead of its critical review in October 2027.

The submission calls for a broader assessment of nicotine science, dependence and public health policy, emphasising the importance of distinguishing nicotine use from the harms of combustible tobacco. International regulatory decisions should consider the potential consequences for smoking cessation and access to lower-risk alternatives.

November 09, 2026 by centerforglobalhealthaccountability.org

Palau and the absurd case for international nicotine prohibition

Palau's proposal to bring nicotine under the UN's international drug control system has raised concerns about the future of tobacco harm reduction.

The initiative seeks a WHO review of nicotine under the Convention on Psychotropic Substances, potentially paving the way for restrictions extending beyond conventional tobacco regulation.

Critics argue that such an approach risks overlooking the significant differences between combustible cigarettes and smoke-free nicotine products. International nicotine policy should distinguish dependence from smoking-related disease and assess whether additional controls would reduce harm or restrict access to lower-risk alternatives.

November 06, 2026 by prohibitiondoesnotwork.com

Istanbul Tobacco Control Conference Pushes War on Safer Nicotine Alternatives

The 11th European Conference on Tobacco Control, held in Istanbul from 4–6 November, has raised concerns over proposals to bring nicotine under international drug control frameworks.

Campaigners are discussing support for Palau's initiative to review nicotine under the UN Convention on Psychotropic Substances, potentially extending restrictions to smoke-free alternatives such as vapes and nicotine pouches.

Critics warn that such measures could undermine tobacco harm reduction by limiting access to lower-risk products while combustible cigarettes remain legally available. The debate highlights the importance of distinguishing nicotine dependence from smoking-related disease and assessing the potential public health consequences of further restrictions.

November 05, 2026 by yonkerstimes.com

Vapes and Quitting Smoking: The Facts May Surprise You

Nicotine vaping can help adults quit smoking, but successful tobacco harm reduction involves more than simply replacing one product with another.

Clinical evidence supports e-cigarettes as a smoking cessation option, particularly for adults who struggle with traditional methods. Complete switching is important, as continued cigarette use alongside vaping may limit the potential health benefits.

Although long-term uncertainties remain, clear information about relative risk, personalised cessation support and realistic quitting plans can help smokers make informed decisions and move away from combustible tobacco.

November 05, 2026 by yonkerstimes.com

Vapes and Quitting Smoking: The Facts May Surprise You

Nicotine vaping can help adults quit smoking, but successful tobacco harm reduction involves more than simply replacing one product with another.

Clinical evidence supports e-cigarettes as a smoking cessation option, particularly for adults who struggle with traditional methods. Complete switching is important, as continued cigarette use alongside vaping may limit the potential health benefits.

Although long-term uncertainties remain, clear information about relative risk, personalised cessation support and realistic quitting plans can help smokers make informed decisions and move away from combustible tobacco.

October 29, 2026 by substack.com

When Listening Becomes Another Way to Lecture

Interviews with 20 illicit tobacco users in New Zealand reveal how financial hardship, nicotine dependence and frustration with tobacco policies influence purchasing decisions.

The findings raise questions about whether public health campaigns focused on changing consumer attitudes adequately address the economic pressures driving illicit sales.

Effective tobacco control should consider affordability, taxation and access to cessation support, including lower-risk nicotine alternatives. Understanding consumers' experiences is essential to developing policies that reduce smoking-related harm rather than reinforce existing barriers.